肿瘤细胞治疗研究
英文原题：When playing the NK cell therapy card in glioblastoma, you can't beat interleukin-21.
When playing the NK cell therapy card in glioblastoma, you can't beat interleukin-21.
胶质母细胞瘤是最常见的脑癌，5年生存率低于10%。
胶质母细胞瘤是最常见的脑癌，5年生存率低于10%。这一严峻的预后凸显了对新型治疗方法的迫切需求。在本期 Cancer Cell 中，Shanley 等 1 报道了一种创新的工程化策略，以增强 NK 细胞对抗胶质母细胞瘤的免疫力。
Glioblastoma is the most common brain cancer, with a 5-year survival rate of less than 10%. This grim prognosis highlights the urgent need for novel therapeutic approaches. In this issue of Cancer Cell, Shanley et al. 1 report an innovative engineering strategy to supercharge NK cell immunity against glioblastoma.
MEMBER ACCOUNT
登录成功会直接打开下一页。
